Dedicated to the advancement of breakthrough medicines and psychedelic therapies,
reMind will host its third annual event — The Psychedelics Business Forum — at MJBizCon
Denver, CO, October 16, 2024 — The reMind Psychedelics Business Forum, in partnership with MJBizCon, will be held at the Las Vegas Convention Center on Tuesday, December 3, 2024.
reMind, a media and events platform focused on building, connecting, and educating diverse communities that responsibly grow the business of psychedelics, returns to Las Vegas for its third annual conference. The one-day program and networking event is designed for business owners, entrepreneurs, policymakers, healthcare providers, and other professionals interested in the latest developments that directly impact the growth of the psychedelics industry.
“While Oregon and Colorado continue to lead the way with state-regulated psychedelic programs, Massachusetts, New Jersey, and dozens of other states may soon have similar programs underway — pushing the psychedelics movement toward a historic inflection point. There’s never been a better time for aspiring businesses, mental health experts, policy advocates, and nonprofits to come together and help steer the future of this critically important industry,” said Sara Vaughn, VP Brand Leader of reMind.
Providing a vibrant meeting ground to connect science and business, industry pioneers will share valuable insights and information, including Sue Sisley MD of the Scottsdale Research Institute, Joel Stanley of AJNA Biosciences, Jodi Green of Antithesis Law, Reggie Harris of Oakland Hyphae/Hyphae Labs, Rome Shadanloo of Mycology Psychology, Joe Moore of Psychedelics Today, Barine Majewska of Vicente LLP, Kat Thompson of Fractal Soul Service Center, and Henry Winslow of Tricycle Day, Bill Levers of Beard Bros Pharms, and Zach Dorsett of Wonderbags.
The event will be emceed by Ricardo Baca, CEO & Founder of Grasslands: A Journalism-Minded Agency, and reMind Advisory Board member.
Featured panel discussions and solo talks, include:
- Oregon, Colorado & Beyond: Deep Dive on State Regulated Programs. Learn directly from owners, facilitators and entrepreneurs about the opportunities and challenges of starting a psychedelic business in the first states to legalize plus what states will come online next.
- Gray Markets: The Good, The Bad and the Jury’s Still Out. Decriminalization is making psychedelic medicine accessible to more people, but there are risks. Learn how to navigate this rapidly evolving marketplace safely and successfully.
- Unlocking the Power of Plant and Psychedelic Medicine. A trailblazing medical researcher reflects on her decades-long fight to be able to study natural plants and fungi (including psilocybin and cannabis) as a safer, more effective alternative to synthetic psychoactive drugs — and how this research has led to a better understanding of the veteran suicide epidemic, opening doors for more compassion and treatment options for members of the armed forces.
- Mushrooms, Microdosing, and Why We Can No Longer Wait for Permission to Heal. A founder shares her personal journey through a fragmented healthcare system, revealing the healing power of psilocybin and why personal autonomy and cognitive liberty are more important than ever.
- ‘Sector Breakdown: ‘Psychedelic-Adjacent’ Products and Services. Everything you need to know about the science, health benefits, and business opportunities of functional mushrooms, kanna, kava, and other legal plant medicines.
- How to Engage Your Cannabis Audience About Psychedelics. Learn about key learnings from the cannabis industry, how the psychedelics business model differs, and where the business opportunities are. Here from experts who have worked in both spaces and how they made that crossover.
reMind is also offers companion digital products on remindmedia.com, including special reports, webinars and the latest updates and insights in the field of psychedelics, including legislation, research, investments, and business news.
Registration is open, here.
If you missed the 2023 reMind Psychedelics Business Forum, watch sessions here.
About reMind
Through digital resources and in-person events, reMind serves as the platform for building, connecting, and educating diverse communities that share a common goal of increasing access to psychedelics and propelling the industry forward. We will provide a vibrant meeting ground to connect science and industry; healthcare and legislation; ancient remedies and modern medicines. As a trusted source of news and insights, we offer facts, not hype. We are unbiased, not on a bandwagon. We bring you the latest updates in psychedelics—including legislation, research, investments, business news, and pharmaceutical trials.
reMind’s advisory board includes Amanda Reiman, Chief Knowledge Officer at New Frontier Data; Scarlet Masius, Creative Strategist & Consultant; Josh Hardman, Founder & Editor of Psychedelic Alpha; Ricardo Baca, CEO & Founder of Grasslands; and Raad Seraj, Founder of Mission Club.
About Emerald
Emerald’s talented and experienced team grows our customers’ businesses 365 days a year through connections, content, and commerce. We expand connections that drive new business opportunities, product discovery, and relationships with over 140 annual events, matchmaking, and lead-gen services. We create content to ensure that our customers are on the cutting edge of their industries and are continually developing their skills. And we power commerce through efficient year-round buying and selling. We do all this by seamlessly integrating in-person and digital platforms and channels. Emerald is immersed in the industries we serve and committed to supporting the communities in which we operate. As true partners, we create experiences that inspire, amaze, and deliver breakthrough results.
